Cullinan Therapeutics, Inc. · NASDAQ:CGEM
Sumer Jacquelyn L received 2,470 Cullinan Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 30, 2026 · Filed Jul 2, 2026
On Jun 30, 2026, Sumer Jacquelyn L (Chief Legal Officer) received 2,470 Cullinan Therapeutics, Inc. shares as an award at US$8.60 for US$21,242, leaving 130,559 shares. Filed Jul 2, 2026 (Form 4).
- Awarded
- 2,470 shares
- Price
- US$8.60
- Value
- US$21,242
- Holding after
- 130,559 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Award | 2,470 | US$8.60 | 130,559 | Direct |
Source
Related
- Cullinan Therapeutics, Inc.
- Sumer Jacquelyn L
- Cullinan Therapeutics, Inc. shareholders
- Form 4 · Michaelson Jennifer · Sep 10, 2026
- Form 4 · Michaelson Jennifer · Aug 14, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026